The Association Between Phthalates and Metabolic Syndrome: the National Health and Nutrition Examination Survey 2001-2010

Overview

Journal Environ Health

Publisher Biomed Central

Specialty Environmental Health

Date 2016 Apr 16

PMID 27079661

Citations 43

Authors

Tamarra M James-Todd

Tianyi Huang

Ellen W Seely

Aditi R Saxena

Affiliations

Soon will be listed here.

Abstract

Background: Higher exposure to certain phthalates is associated with a diabetes and insulin resistance, with sex differences seen. Yet, little is known about the association between phthalates and metabolic syndrome (MetS), particularly with consideration for differences by sex and menopausal status.

Methods: We analyzed data from 2719 participants in the National Health and Nutrition Examination Survey (NHANES) 2001-2010 aged 20-80 years. Five urinary phthalate metabolites (MEP, MnBP, MiBP, MBzP, and MCPP) and DEHP metabolites were analyzed by the Centers for Disease Control and Prevention and were evaluated as population-specific quartiles. MetS was defined by National Cholesterol Education Program's Adult Treatment Panel III report criteria. Prevalence odds ratios (POR) and 95 % confidence intervals (CI) were calculated using multivariable logistic regression, adjusting for potential confounders and stratifying by sex and menopausal status.

Results: Participants with MetS (32 % of the study population) had higher concentrations for all urinary phthalate metabolites. After full adjustment, higher DEHP metabolite concentrations were associated with an increased odds of MetS in men, but not women (adj. POR for men Q4 versus Q1: 2.20; 95 % CI: 1.32, 3.68 and adj. POR for women Q4 versus Q1: 1.50; 95 % CI: 0.89, 2.52). When evaluating by menopausal status, pre-menopausal women with higher concentrations of MBzP had close to a 4-fold increased odds of MetS compared to pre-menopausal women with the lowest concentrations of MBzP (adj POR: Q4 versus Q1: 3.88; 95 % CI: 1.59, 9.49).

Conclusions: Higher concentrations of certain phthalate metabolites were associated with an increased odds of MetS. Higher DEHP metabolite concentrations were associated with an increased odds of MetS for men. In women, the strongest association was between higher concentrations of MBzP and MetS, but only among pre-menopausal women.

Citing Articles

Integrating New Approach Methodologies to Address Environmental Pancreatic Toxicity and Metabolic Disorders.

Ge Y Biology (Basel). 2025; 14(1).

PMID: 39857315 PMC: 11762660. DOI: 10.3390/biology14010085.

Associations of Phthalate Exposure With Adiposity and Metabolic Syndrome in US Adolescents and Adults, NHANES 2013 to 2018.

Webb M, Park J, Day D, Trabulsi J, Sathyanarayana S, Melough M J Endocr Soc. 2024; 8(12):bvae189.

PMID: 39569134 PMC: 11578596. DOI: 10.1210/jendso/bvae189.

Phthalates are detected in the follicular fluid of adolescents and oocyte donors with associated changes in the cumulus cell transcriptome.

Gokyer D, Laws M, Kleinhans A, Riley J, Flaws J, Babayev E F S Sci. 2024; 6(1):30-41.

PMID: 39515754 PMC: 11829829. DOI: 10.1016/j.xfss.2024.10.009.

Walnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.

Ali G, Zeb A, Usman M, Al-Babili S Food Sci Nutr. 2024; 12(10):8340-8352.

PMID: 39479714 PMC: 11521631. DOI: 10.1002/fsn3.4405.

MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.

Gil-Redondo R, Conde R, Bruzzone C, Seco M, Bizkarguenaga M, Gonzalez-Valle B Cardiovasc Diabetol. 2024; 23(1):272.

PMID: 39048982 PMC: 11271192. DOI: 10.1186/s12933-024-02363-3.

References

Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon M, Heymsfield S . The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003; 163(4):427-36. PMC: 3146257. DOI: 10.1001/archinte.163.4.427. View

Okubo T, Suzuki T, Yokoyama Y, Kano K, Kano I . Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol Pharm Bull. 2003; 26(8):1219-24. DOI: 10.1248/bpb.26.1219. View

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-8. DOI: 10.1161/01.CIR.0000111245.75752.C6. View

Silva M, Barr D, Reidy J, Malek N, Hodge C, Caudill S . Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect. 2004; 112(3):331-8. PMC: 1241863. DOI: 10.1289/ehp.6723. View

Ford E . Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am. 2004; 33(2):333-50. DOI: 10.1016/j.ecl.2004.03.004. View

Wisse B . The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004; 15(11):2792-800. DOI: 10.1097/01.ASN.0000141966.69934.21. View

Lerner D, Kannel W . Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986; 111(2):383-90. DOI: 10.1016/0002-8703(86)90155-9. View

Reaven G . Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988; 37(12):1595-607. DOI: 10.2337/diab.37.12.1595. View

DeFronzo R, Ferrannini E . Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14(3):173-94. DOI: 10.2337/diacare.14.3.173. View

10.

Ford E . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28(7):1769-78. DOI: 10.2337/diacare.28.7.1769. View

11.

Hauser R, Calafat A . Phthalates and human health. Occup Environ Med. 2005; 62(11):806-18. PMC: 1740925. DOI: 10.1136/oem.2004.017590. View

12.

Duty S, Ackerman R, Calafat A, Hauser R . Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect. 2005; 113(11):1530-5. PMC: 1310914. DOI: 10.1289/ehp.8083. View

13.

Eberly L, Prineas R, Cohen J, Vazquez G, Zhi X, Neaton J . Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care. 2005; 29(1):123-30. DOI: 10.2337/diacare.29.1.123. View

14.

Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E . Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diabetes Care. 2006; 29(6):1363-9. DOI: 10.2337/dc05-2385. View

15.

Meigs J, Wilson P, Fox C, Vasan R, Nathan D, Sullivan L . Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91(8):2906-12. DOI: 10.1210/jc.2006-0594. View

16.

Galassi A, Reynolds K, He J . Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006; 119(10):812-9. DOI: 10.1016/j.amjmed.2006.02.031. View

17.

McLaughlin T, Abbasi F, Lamendola C, Reaven G . Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med. 2007; 167(7):642-8. DOI: 10.1001/archinte.167.7.642. View

18.

Stahlhut R, van Wijngaarden E, Dye T, Cook S, Swan S . Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007; 115(6):876-82. PMC: 1892109. DOI: 10.1289/ehp.9882. View

19.

Hatch E, Nelson J, Qureshi M, Weinberg J, Moore L, Singer M . Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health. 2008; 7:27. PMC: 2440739. DOI: 10.1186/1476-069X-7-27. View

20.

Chichlowska K, Rose K, Diez-Roux A, Golden S, McNeill A, Heiss G . Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) Study. Psychosom Med. 2008; 70(9):986-92. PMC: 2993075. DOI: 10.1097/PSY.0b013e318183a491. View